Home » Newsletters » BioWorld Science

BioWorld Science

April 22, 2013

View Archived Issues

Uncovering purinergic signaling as a potential drug target for autism spectrum disorders

New panels for prostate cancer diagnosis described

Johnson & Johnson reports achievements of first quarter 2013

GlaxoSmithKline presents novel PI3Kdelta inhibitors for treatment of respiratory diseases

NKTR-214 is significantly more efficacious in vivo compared to aldesleukin

CA6 is a potential novel gene biomarker for atopic dermatitis

Novel TYK2 inhibitors presented by Roche

Roche patents new CYP11B2 inhibitors

Novel tyrosine kinase inhibitors designed at Cellzome

Novel pan-pim inhibitor limits multiple myeloma tumor growth in vivo

Meiji Seika Pharma begins clinical testing of novel antifungal agent

Cipla launches biosimilar of etanercept in India

Afraxis identifies new PAK inhibitors

Novel EGFR inhibitors designed at Pfizer

Improvements in lung function observed in study of VX-661 and ivacaftor

Novel IRAK-4 inhibitors prepared at Aurigene Discovery

Pieris achieves second milestone under Anticalin collaboration

Lundbeck launches Selincro in European markets

Elan rejects Royalty Pharma's acquisition offer

Cerecor acquires rights to MK-0657 from Merck & Co.

Ceregene announces findings from phase IIb gene therapy study for Parkinson's disease

Phase II study of BI-505 in multiple myeloma begins

TiGenix reports phase IIa study results for Cx-611

BIND Therapeutics and AstraZeneca collaborate on cancer nanomedicine

FDA designates LJPC-6417 as an orphan drug product

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...